ArticleArtificial organs2026
When Technology Falters: Ensuring Donor Safety and System Reliability Amid Apheresis Technical Challenges.
Article in Artificial organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When Technology Falters: Ensuring Donor Safety and System Reliability Amid Apheresis Technical Challenges.Artificial organs · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the rising demand for platelet products, the use of apheresis-derived single donor platelets (SDPs) has grown substantially. While plateletpheresis is generally considered safe, it is not devoid of complications. This retrospective descriptive study reviews three adverse events that occurred during SDP collection at a transfusion medicine department. Root cause analysis (RCA) was employed using tools such as the 5 "Whys" technique and the Ishikawa (Fishbone) Diagram to identify underlying causes and propose preventive strategies. In the first incident, a first-time donor experienced vasovagal symptoms triggered by a visible blood leak from the apheresis kit. The second incident involved a centrifuge alarm and mid-procedure halt due to blood spillage caused by improper kit installation. The third incident was identified post-procedure when the platelet concentrate was found contaminated with red blood cells from a manufacturing defect. All donors recovered without lasting health effects; however, such technical or procedural failures can erode donor confidence, reduce willingness for repeat donations, and impact retention of valuable apheresis donors. The events in this case series highlight that adverse outcomes can stem from both equipment-related faults and human errors. Strengthening the voluntary apheresis donor base in India requires prioritizing donor safety, ensuring positive donation experiences, comprehensive staff training, adherence to standard operating procedures (SOPs), and fostering a supportive, trust-based environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.